Adagene Inc.

As of June 30, 2026, Adagene Inc. carries a market capitalization of 346.88M, placing it among publicly traded companies globally. Its enterprise value stands at 225.06M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Adagene Inc.'s next confirmed earnings release is scheduled for March 31, 2027.

As of June 30, 2026, Adagene Inc. has 82.59M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, Adagene Inc. maintains a current ratio of 5.02, meaning it holds 5.0x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2026.

As of the close on November 4, 2026, Adagene Inc.'s stock has gained approximately 41.76% over the past 52 weeks. The 50-day moving average sits at 2.96, while the 200-day moving average is 3.43.

As of June 30, 2026, Adagene Inc. holds 127.91M in cash and equivalents against 6.09M in total debt, resulting in a net debt position of -122.18M. Total book value stands at 89.45M, with working capital of 106.05M providing operational flexibility.